VALIANT LABORATORIES LTD Share Price

₹ 123.33

-₹2.51 (-1.99%)
1D
Last updated 03 Nov, 2026, 15:14 IST
NSE: VALIANTLAB
|
Pharmaceuticals

VALIANT LABORATORIES LTD Share Price Today

As of 4 Nov 2026, VALIANT LABORATORIES LTD share price is ₹123.33. The stock opened at ₹123.33, compared to its previous close of ₹125.84. During today's trading session, VALIANT LABORATORIES LTD share price moved in the range of ₹123.33 to ₹123.33, with an average price of ₹123.33 for the day. Looking at its last 52-week, the stock has touched a low of ₹49.51 and a high of ₹141.38.

Share price over the last 1 day fell from 127.10 to 123.33, ranging between 123.33 and 127.10.
₹123.33
1.99% down today
₹123.33
1D LOW
1D HIGH

VALIANT LABORATORIES LTD Stock Insights

Latest Earning
Op Profit TrendUp by 2394.29% QoQ
Latest Earning
Net Profit TrendUp by 1098.86% QoQ
Latest Earning
Revenue TrendUp by 26.04% QoQ
Stock Performance
OutperformingBeat Nifty by 107.15 % in last 3 month
VALIANT LABORATORIES LTD stock performance
Open₹123.33
High₹123.33
Low₹123.33
Prev. close₹125.84
VALIANT LABORATORIES LTD trading activity
Volume9,901
Average traded price₹123.33
Last traded time03:14:11 03 Nov
Last traded quantity5
Circuit
L
H
₹123.33
₹128.35
52-week
L
H
₹49.51
₹141.38
Mkt Cap Cr
684.34
P/E
42.71
P/B
2.2
ROA
3.45%
ROE
-1.05%
ROCE
0.74%
Quick Ratio
1.53
EV/EBITDA
20.58

Based on fundamentals, this stock's

Performance: 4 out of 5, Good
Performance
Good
Valiant Laborato outperforming most market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Valiant Laborato appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Valiant Laborato revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,64,141.2490.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,300.8316.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

VALIANT LABORATORIES LTD Company Background

ISIN
INE0JWS01017
Sector Market Cap
₹ 684.34 Cr

Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

VALIANT LABORATORIES LTD Financial Highlights

  • Revenue: VALIANT LABORATORIES LTD reported revenue of ₹239.79 crore in FY26 vs ₹138.81 crore in FY25. It showed an increase of 72.75% on a yearly basis.
  • Operating Profit: VALIANT LABORATORIES LTD reported an operating profit of ₹0.77 crore in FY26 vs ₹1.51 crore in FY25. It showed an increase of 150.99% on a year-on-year basis.
  • Net Profit: VALIANT LABORATORIES LTD reported a net loss of ₹3.27 crore in FY26 vs ₹2.20 crore in FY25. It showed a decrease of 48.64% on a yearly basis.

VALIANT LABORATORIES LTD Quarterly Result Highlights

  • VALIANT LABORATORIES LTD reported revenue of ₹116.15 crore in Jun 2026, compared with ₹92.15 crore in Mar 2026, representing an increase of 26.04% on a quarter-on-quarter (QoQ) basis.
  • VALIANT LABORATORIES LTD reported an operating profit of ₹26.19 crore in Jun 2026, compared with ₹1.05 crore in Mar 2026, representing an increase of 2,394.29% on a quarter-on-quarter (QoQ) basis.
  • VALIANT LABORATORIES LTD reported a profit of ₹21.10 crore in Jun 2026, compared with ₹1.76 crore in Mar 2026, reflecting an increase of 1,098.86% on a QoQ basis.
  • The earnings per share (EPS) of VALIANT LABORATORIES LTD stood at ₹0.65 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
74.94%
FII
0.07%
Other DII
0.08%
Retail and other
24.91%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.01%
Mar 20260.20%
Jun 20260.00%
Sep 20260.07%

VALIANT LABORATORIES LTD Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

VALIANT LABORATORIES LTD Share Price History

VALIANT LABORATORIES LTD share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹123.33 / ₹123.33
-1.99%
02 Nov 26
₹125.85 / ₹125.84
-1.99%
30 Oct 26
₹130.88 / ₹128.40
+0.05%
29 Oct 26
₹125.00 / ₹128.33
+1.99%
Show more

VALIANT LABORATORIES LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹237.47₹133.38₹182.06₹333.91
Other Income₹2.32₹5.43₹9.68₹4.86
Total Revenue₹239.79₹138.82₹191.74₹338.77
Total Expenses₹239.02₹140.33₹192.51₹300.64
Profit Before Tax₹0.77-₹1.51-₹0.77₹38.14
Tax₹4.04₹0.69-₹1.09₹9.14
Profit After Tax-₹3.27-₹2.20₹0.32₹29.00
EPS - Basic-₹0.65-₹0.51₹0.13₹8.91
EPS - Diluted-₹0.65-₹0.51₹0.13₹8.91

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.77-₹1.51-₹0.77₹38.14
Income before WC changes₹7.66₹2.78₹1.27₹39.69
Change in Assets-₹77.47-₹18.87₹22.89₹20.14
Change in Liabilities₹60.39₹14.94-₹23.26₹5.02
Change in WC-₹17.08-₹3.93-₹0.37₹25.16
Cash flow from Operations-₹10.43₹1.31₹1.89₹56.05
Cash flow from Investing₹7.25-₹52.77-₹143.88-₹55.17
Cash flow from Financing₹1.79₹44.65₹152.45-₹0.93
Total Cash Flow-₹1.39-₹6.80₹10.46-₹0.05
Cash (Start of the year)₹4.92₹11.72₹1.26₹1.31
Cash (End of the year)₹3.53₹4.92₹11.72₹1.26

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹235.65₹208.24₹117.14₹62.39
Current Assets₹228.32₹192.62₹225.54₹150.58
Total Assets₹463.98₹400.86₹342.69₹212.97
Current Liabilities₹119.45₹59.62₹29.08₹50.73
Net Current Asset₹108.88₹133.00₹196.47₹99.85
Non-Current Liabilities₹33.65₹106.93₹76.75₹61.75
Equity Capital₹310.89₹234.31₹236.86₹100.49
Total Equity & Liabilities₹463.98₹400.86₹342.69₹212.97

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹217.04₹133.36₹182.05₹333.91
Other Income₹2.89₹5.43₹9.68₹4.86
Total Revenue₹219.94₹138.79₹191.73₹338.77
Total Expenses₹212.39₹140.24₹192.49₹300.64
Profit Before Tax₹7.55-₹1.45-₹0.75₹38.14
Tax₹2.00₹0.70-₹1.09₹9.14
Profit After Tax₹5.55-₹2.15₹0.34₹29.00
EPS - Basic₹1.10-₹0.50₹0.14₹8.91
EPS - Diluted₹1.10-₹0.50₹0.14₹8.91

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹7.55-₹1.45-₹0.75₹38.14
Income before WC changes₹9.16₹2.77₹1.27₹39.95
Change in Assets-₹64.26-₹22.27₹70.90-₹7.39
Change in Liabilities₹42.30-₹5.59-₹24.37-₹0.81
Change in WC-₹21.96-₹27.86₹46.53-₹8.20
Cash flow from Operations-₹13.81-₹21.90₹48.78₹22.96
Cash flow from Investing-₹8.09₹24.97-₹182.73-₹21.18
Cash flow from Financing₹20.17-₹0.50₹135.80-₹1.53
Total Cash Flow-₹1.73₹2.57₹1.85₹0.24
Cash (Start of the year)₹4.80₹2.23₹0.38₹0.13
Cash (End of the year)₹3.07₹4.80₹2.23₹0.38

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹196.57₹198.06₹115.46₹30.80
Current Assets₹189.32₹119.22₹209.27₹181.96
Total Assets₹385.89₹317.28₹324.73₹212.76
Current Liabilities₹62.68₹20.95₹26.36₹50.52
Net Current Asset₹126.64₹98.27₹182.90₹131.44
Non-Current Liabilities₹3.46₹61.95₹61.48₹61.75
Equity Capital₹319.76₹234.38₹236.88₹100.49
Total Equity & Liabilities₹385.89₹317.28₹324.73₹212.76
* All values are in INR Crore
VALIANT LABORATORIES LTD market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
VALIANT LABORATORIES LTD technical summary
Bearish indicators0
Neutral indicators5
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
52.31
Neutral
ATR (14)
4.91
Neutral
STOCH(9,6)
28.23
Neutral
STOCH RSI (14)
8.48
Bullish
ADX(9)
14.94
Bullish
UO(9)
47.46
Neutral
ROC(12)
2.78
Bullish
WillR(14)
-66.47
Neutral
Period
Simple value
Exponential vaue
5D
126.35
127.05
10D
129.16
127.31
20D
126.34
125.96
50D
118.4
115.79
100D
92.67
101.36
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

VALIANT LABORATORIES LTD
Pharmaceuticals
Add Stock
Add Another

VALIANT LABORATORIES LTD Returns Calculator

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

VALIANT LABORATORIES LTD Share Price FAQs

Please be aware that VALIANT LABORATORIES LTD stock prices are subject to continuous fluctuations due to various factors.